Evidence map›Paper›PMID 36743879›Full record

ArticleCase reports in oncology

Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.

Yue Mounai, Taichi Yoshida, Shogo Ito, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hanae Shinozaki, Daichi Takagi, Kazuhiro Imai, Hiroshi Yamamoto and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinical activity of pembrolizumab in refractoryTherapeutic advances in medical oncology · 2024
    Article
  5. Primary pulmonary artery chondrosarcoma: case report.Translational cancer research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yue MounaiDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Taichi YoshidaDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Shogo ItoDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Koji FukudaDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Kazuhiro ShimazuDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Daiki TaguchiDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Hanae ShinozakiDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Daichi TakagiDepartment of Cardiovascular Surgery, Graduate School of Medicine, Akita University, Akita, Japan.
Kazuhiro ImaiDepartment of Thoracic Surgery, Graduate School of Medicine, Akita University, Akita, Japan.
Hiroshi YamamotoDepartment of Cardiovascular Surgery, Graduate School of Medicine, Akita University, Akita, Japan.
Yoshihiro MinamiyaDepartment of Thoracic Surgery, Graduate School of Medicine, Akita University, Akita, Japan.
Hiroshi NanjyoDepartment of Pathology, Akita University Hospital, Akita, Japan.
Hiroyuki ShibataDepartment of Clinical Oncology, Graduate School of Medicine, Akita University, Akita, Japan.
Akita University · JPAkita University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intimal sarcoma is an extremely rare mesenchymal tumor arising in the great vessels. To date, intimal sarcoma has not been reported in patients with Lynch syndrome (LS), even though this syndrome lacks DNA mismatch repair ability genetically and is prone to various malignancies. This patient was diagnosed with LS by the Revised Amsterdam Criteria II, and she suffered from intimal sarcoma in the left pulmonary artery. She had a germline missense variant of

Indexed as

Immune checkpoint inhibitorIntimal sarcomaLynch syndrome

Identifiers

PMID36743879
PMCPMC9891846
OpenAlexW4318261998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.